Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

被引:644
作者
Gide, Tuba N. [1 ,2 ]
Quek, Camelia [1 ,2 ]
Menzies, Alexander M. [1 ,2 ,3 ,4 ]
Tasker, Annie T. [1 ]
Shang, Ping [1 ]
Holst, Jeff [2 ,5 ]
Madore, Jason [1 ]
Lim, Su Yin [1 ,6 ]
Velickovic, Rebecca [1 ]
Wongchenko, Matthew [7 ]
Yan, Yibing [7 ]
Lo, Serigne [1 ]
Carlino, Matteo S. [1 ,2 ,8 ,9 ]
Guminski, Alexander [1 ,2 ,3 ,4 ]
Saw, Robyn P. M. [1 ,2 ,10 ]
Pang, Angel [2 ,5 ]
McGuire, Helen M. [11 ,12 ]
Palendira, Umaimainthan [2 ,5 ]
Thompson, John F. [1 ,2 ,10 ]
Rizos, Helen [1 ,6 ]
da Silva, Ines Pires [1 ,2 ]
Batten, Marcel [1 ,2 ]
Scolyer, Richard A. [1 ,2 ,10 ]
Long, Georgina V. [1 ,2 ,3 ,4 ]
Wilmott, James S. [1 ,2 ]
机构
[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2065, Australia
[2] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia
[3] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW 2065, Australia
[4] Mater Hosp, Dept Med Oncol, Sydney, NSW 2060, Australia
[5] Univ Sydney, Centenary Inst, Sydney, NSW 2050, Australia
[6] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia
[7] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA
[8] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW 2145, Australia
[9] Blacktown Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW 2145, Australia
[10] Royal Prince Alfred Hosp, Sydney, NSW 2050, Australia
[11] Univ Sydney, Charles Perkins Ctr, Ramaciotti Facil Human Syst Biol, Sydney, NSW 2006, Australia
[12] Univ Sydney, Fac Med & Hlth, Sch Med Sci, Discipline Pathol, Sydney, NSW 2006, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
CARBONIC-ANHYDRASE IX; CD8; T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; CTLA-4; BLOCKADE; INHIBITORY RECEPTORS; COMBINATION THERAPY; CLINICAL-RESPONSE; PD-L1; EXPRESSION; DENDRITIC CELLS; MASS-CYTOMETRY;
D O I
10.1016/j.ccell.2019.01.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer immunotherapies provide survival benefits in responding patients, but many patients fail to respond. Identifying the biology of treatment response and resistance are a priority to optimize drug selection and improve patient outcomes. We performed transcriptomic and immune profiling on 158 tumor biopsies from melanoma patients treated with anti-PD-1 monotherapy (n = 63) or combined anti-PD-1 and anti-CTLA-4 (n = 57). These data identified activated T cell signatures and T cell populations in responders to both treatments. Further mass cytometry analysis identified an EOMES(+)CD69(+)CD45RO(+) effector memory T cell phenotype that was significantly more abundant in responders to combined immunotherapy compared with non-responders (n = 18). The gene expression profile of this population was associated with longer progression-free survival in patients treated with single agent and greater tumor shrinkage in both treatments.
引用
收藏
页码:238 / +
页数:24
相关论文
共 84 条
  • [1] HTSeq-a Python']Python framework to work with high-throughput sequencing data
    Anders, Simon
    Pyl, Paul Theodor
    Huber, Wolfgang
    [J]. BIOINFORMATICS, 2015, 31 (02) : 166 - 169
  • [2] CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
    Anderson, Matthew W.
    Zhao, Shuchun
    Freud, Aharon G.
    Czerwinski, Debra K.
    Kohrt, Holbrook
    Alizadeh, Ash A.
    Houot, Roch
    Azambuja, Denize
    Biasoli, Irene
    Morais, Jose Carlos
    Spector, Nelson
    Molina-Kirsch, Hernan F.
    Warnke, Roger A.
    Levy, Ronald
    Natkunam, Yasodha
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (03) : 795 - 803
  • [3] The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma
    Ascierto, Maria Libera
    McMiller, Tracee L.
    Berger, Alan E.
    Danilova, Ludmila
    Anders, Robert A.
    Netto, George J.
    Xu, Haiying
    Pritchard, Theresa S.
    Fan, Jinshui
    Cheadle, Chris
    Cope, Leslie
    Drake, Charles G.
    Pardoll, Drew M.
    Taube, Janis M.
    Topalian, Suzanne L.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (09) : 726 - 733
  • [4] IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
    Ayers, Mark
    Lunceford, Jared
    Nebozhyn, Michael
    Murphy, Erin
    Loboda, Andrey
    Kaufman, David R.
    Albright, Andrew
    Cheng, Jonathan D.
    Kang, S. Peter
    Shankaran, Veena
    Piha-Paul, Sarina A.
    Yearley, Jennifer
    Seiwert, Tanguy Y.
    Ribas, Antoni
    McClanahan, Terrill K.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) : 2930 - 2940
  • [5] 4-1 BB agonists: multi-potent potentiators of tumor immunity
    Bartkowiak, Todd
    Curran, Michael A.
    [J]. FRONTIERS IN ONCOLOGY, 2015, 5
  • [6] Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
    Bendall, Sean C.
    Simonds, Erin F.
    Qiu, Peng
    Amir, El-ad D.
    Krutzik, Peter O.
    Finck, Rachel
    Bruggner, Robert V.
    Melamed, Rachel
    Trejo, Angelica
    Ornatsky, Olga I.
    Balderas, Robert S.
    Plevritis, Sylvia K.
    Sachs, Karen
    Pe'er, Dana
    Tanner, Scott D.
    Nolan, Garry P.
    [J]. SCIENCE, 2011, 332 (6030) : 687 - 696
  • [7] Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
    Blackburn, Shawn D.
    Shin, Haina
    Haining, W. Nicholas
    Zou, Tao
    Workman, Creg J.
    Polley, Antonio
    Betts, Michael R.
    Freeman, Gordon J.
    Vignali, Dario A. A.
    Wherry, E. John
    [J]. NATURE IMMUNOLOGY, 2009, 10 (01) : 29 - 37
  • [8] Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
    Blackburn, Shawn D.
    Shin, Haina
    Freeman, Gordon J.
    Wherry, E. John
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (39) : 15016 - 15021
  • [9] Trimmomatic: a flexible trimmer for Illumina sequence data
    Bolger, Anthony M.
    Lohse, Marc
    Usadel, Bjoern
    [J]. BIOINFORMATICS, 2014, 30 (15) : 2114 - 2120
  • [10] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
    Brahmer, Julie
    Reckamp, Karen L.
    Baas, Paul
    Crino, Lucio
    Eberhardt, Wilfried E. E.
    Poddubskaya, Elena
    Antonia, Scott
    Pluzanski, Adam
    Vokes, Everett E.
    Holgado, Esther
    Waterhouse, David
    Ready, Neal
    Gainor, Justin
    Aren Frontera, Osvaldo
    Havel, Libor
    Steins, Martin
    Garassino, Marina C.
    Aerts, Joachim G.
    Domine, Manuel
    Paz-Ares, Luis
    Reck, Martin
    Baudelet, Christine
    Harbison, Christopher T.
    Lestini, Brian
    Spigel, David R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) : 123 - 135